High-growth diabetes company Diabeloop closes its Series C financing round – led by LBO France, joined by Terumo Corporation, Innovacom and backed by Diabeloop’s historical partners – to power the company’s commercial roll-out and global expansion. (PRESS RELEASE) PARIS, 2-Jun-2022 … Read the full press release
Posted in Artificial Intelligence (AI), Denmark, Financial, France, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged AGIR A DOM., AI, automated insulin delivery, Catherine Dunand, CEMAG invest, CERITD, CGM, Continuous Glucose Monitoring device, Credit Agricole, DBL-hu, DBLG1, DBLG1 System, Diabeloop, Diabetes, Erik Huneker, financing round, Hikaru Samejima, Innovacom, insulin, Kreaxi, LBO France, ML software for diabetes treatment, Odyssée Venture, Promontoires, Series C, Series C financing round, Sofimac, Stéphanie JEGU, Supernova Invest, T1D, Terumo, Terumo Corporation, therapeutic AI, therapeutic artificial intelligence, type 1 diabetes, UI Investissement, Valery Huot
(PRESS RELEASE) PARIJS, 2-Jun-2021 — /EuropaWire/ — Vanaf het begin heeft Diabeloop innovatieve systemen ontwikkeld om de behandeling van diabetes type 1 te automatiseren en te personaliseren, waarbij altijd rekening wordt gehouden met de optiek van de patiënt. Het Franse … Read the full press release
Posted in Belgium, France, Healthcare, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged algoritme, ATTD 2021, ATTD2021, Bernhard Gehr, CEA-Leti, CERITD, DBLG1, DBLG1 AID-systeem, DBLG1 System, DBLG1 System met Accu-Check Insight, DBLG1-algoritme, Diabeloop, Diabetes, diabetes type 1, diabetesbehandeling, diabetologen, diabetoloog, Dr. Guillaume Charpentier, Erik Huneker, gepersonaliseerde behandeling, insulinedosis, m&i Fachklinik Bad Heilbrunn, Marc Julien, Nicole Wetzels, Roche Diabetes Care, T1D, Yousra Tourki, zelflerend algoritme
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
